The FDA advised that Boston Scientific has recalled the carotid Wallstent monorail endoprosthesis. The advisory stated that t ...

Abbott announced it has received European CE Mark approval for the Esprit below-the-knee (BTK) everolimus-eluting resorbable ...

The FDA announced it has commenced daily publication of adverse event data from the FDA Adverse Event Reporting System (FAERS ...

Otsuka Medical Devices Co., Ltd. announced that the Paradise ultrasound renal denervation (uRDN) system has received manufacturi ...

Cook Medical announced that the FDA has granted approval for the company to initiate an investigational device exemption (IDE ...

RenovoRx, Inc. announced an update of its ongoing pivotal phase 3 TIGeR-PaC trial, which is evaluating the company’s first ...

August 20, 2025—enVVeno Medical Corporation announced that it has received a not-approvable letter from the FDA in response to its premarket app ...

Venova Medical announced FDA investigational device exemption (IDE) approval to initiate the VENOS-3 pivotal study of the compan ...

A summary of clinical outcomes from the Vascular and Endovascular Access Society (SAVE)* patient registry in Brazil, ...

Patient throughput and management of GI bleeds, from initial presentation through definitive management. Gastrointestinal (GI ...

A summary of my center’s experience in the WAVE pivotal trial, what makes the WRAPSODY Cell-Impermeable Endoprosthesis (CIE) ...

A Q&A addressing common questions around coding, payment models, and value-based care alignment for percutaneous transmural ...